Navigation Links
Osteotech Announces Fourth Quarter and Full Year Earnings Release and Conference Call Schedule
Date:2/15/2008

EATONTOWN, N.J., Feb. 15 /PRNewswire-FirstCall/ -- Osteotech, Inc. (Nasdaq: OSTE) announced today that the Company's fourth quarter and year ended December 31, 2007 financial results will be released Wednesday, February 20, 2008. A conference call will be conducted by Sam Owusu-Akyaw, President and Chief Executive Officer, as well as other members of Osteotech management, on Wednesday, February 20, 2008, at 9:00 a.m. Eastern time. You are invited to listen to the conference call by dialing 1-706-643-1624. Automated playback will be available two hours after completion of the live call through midnight, Wednesday, March 5, 2008 by dialing 1-706-645-9291 and indicating access code 34462919.

A live, listen-only webcast of our conference call will also be available at our investor site at http://www.osteotech.com on the Financial Highlights page. A replay of the conference call and the question/answer session will be available at the Company's website for approximately 14 days following the call. It will be necessary to have RealPlayer installed on your computer.

Osteotech, Inc., headquartered in Eatontown, New Jersey, is a global leader in providing OsteoBiologic solutions for regenerative medicine to support surgeons and their patients in the repair of the musculoskeletal system through the development of innovative therapy-driven products that alleviate pain, promote biologic healing and restore function. For further information regarding Osteotech, this press release or the conference call, please go to Osteotech's website at http://www.osteotech.com.


'/>"/>
SOURCE Osteotech, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Osteotech to Present at Sidoti Conference in San Francisco
2. Osteotech to Present at Roth Capital Partners 2007 New York Investor Conference
3. Keryx Biopharmaceuticals Announces Additions to Management Team
4. Sigma-Aldrich Announces New Prestige Antibodies(TM) Line for Proteomics and Cell Biology Researchers
5. Exelixis Announces Full Year and Fourth Quarter 2007 Financial Results
6. Tianyin Pharmaceutical Co., Inc. Announces Second Quarter 2008 Financial Results
7. Telik Announces Year-End Financial Release, Conference Call and Webcast
8. Onyx Pharmaceuticals Announces Fourth Quarter and Full Year 2007 Financial Results Teleconference and Webcast
9. GeoPharma Announces Record Revenues in Third Quarter Results
10. Angiotech announces results for the fourth quarter ended December 31, 2007
11. Cell Therapeutics, Inc. (CTI) Announces Cancellation of Approximately $9.1 Million of Existing Notes due 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... ... January 17, 2017 , ... One Million Solutions in Health ... million in investment towards 15+ TEC Validation Projects™. As a pre-competitive consortium, ... in drug safety assessment, for the industry as a whole. , Through the ...
(Date:1/16/2017)... ... January 16, 2017 , ... Appellate Court of New ... the appeal filed by India-based Dishman Pharmaceutical & Chemical Ltd. company (DPCL) for ... one of its Dishman Group’s 100% wholly owned New Jersey-based subsidiary Dishman USA ...
(Date:1/14/2017)... -- The Alliance for Safe Biologic Medicines (ASBM) today issued ... guidance on biologic naming: We commend ... importance of distinct naming for all biologics, including biosimilars. ... will bring to patients, including new treatment options and ... the Guidance dealing with suffix design remains at odds ...
(Date:1/13/2017)... Island, NY (PRWEB) , ... January 13, 2017 ... ... teamed up with several companies to offer its customers three new solutions for ... probe would come in handy if a customer has an oddly-shaped sample that ...
Breaking Biology Technology:
(Date:12/16/2016)... , Dec. 16, 2016 The global wearable medical device ... billion by 2021 from USD 5.31 billion in 2016, at a ... ... driven by technological advancements in medical devices, launch of a growing ... for wireless connectivity among healthcare providers, and increasing focus on physical ...
(Date:12/15/2016)... 2016   WaferGen Bio-systems, Inc. (NASDAQ: ... announced today that on December 13, 2016, it received ... Nasdaq Stock Market LLC which acknowledged that, as of ... common stock had been at $1.00 or greater for ... with Listing Rule 5550(a)(2) of the Nasdaq Stock Market. ...
(Date:12/15/2016)... Dec. 15, 2016 Advancements in ... health wellness and wellbeing (HWW), and security ... three new passenger vehicles begin to feature ... recognition, heart beat monitoring, brain wave monitoring, ... monitoring, and pulse detection. These will be ...
Breaking Biology News(10 mins):